跳至主要内容
临床试验/CTRI/2022/02/040309
CTRI/2022/02/040309尚未招募未知

Clinical study to evaluate the Yogvahi action of Rasasindoor with aqueous extract of Eclipta alba in management of Essential Hypertension

SHRI KRISHNA AYUSH UNIVERSITY KURUKSHETRA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients who already diagnosed as E.H.T will be selected.
  • 2.Patients with Stage 1 Hypertension(having systolic B.P. upto 160 and diastolic B.P. upto 100 )will be selected for the study.
  • 3.Patients willing to give written inform consent to participate in the study

排除标准

  • 1.Essential hypertension with any complications.
  • Renal diseases, Diabetic mellitus
  • 2.Pregnancy induced hypertension.
  • 3.Patients using drugs like oral contraceptive pills, steroids.
  • 4.Ventricular hypertrophy, secondary hypertension, coarctation of aorta.
  • Portal hypertension
  • 5.Renal artery stenosis induced hypertension
  • 6.Patients who enroll in some other clinical trial.

研究者

发起方
SHRI KRISHNA AYUSH UNIVERSITY KURUKSHETRA

相似试验